Drug Profile
Trantinterol
Alternative Names: Trantinterol hydrochlorideLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Jinzhou Jiutai Pharmaceutical; Shenyang Pharmaceutical University
- Developer Jinzhou Jiutai Pharmaceutical
- Class Antiasthmatics; Bronchodilators; Ethanolamines
- Mechanism of Action Beta 2 adrenergic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Asthma
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Asthma(In the elderly, In volunteers) in China
- 01 May 2012 Phase-I clinical trials in Asthma in China (unspecified route)